feed,title,long_url,short_url
SeekingAlpha,Subscribers take spotlight ahead of Neftlix's upcoming Q4 report,https://seekingalpha.com/news/3788906,
SeekingAlpha,Revelation Biosciences falls 21% amid announcement of dosing in phase 1b REVTx-99 study,https://seekingalpha.com/news/3788907,
